
Study Period | 2020 - 2030 |
Market Size (2025) | USD 2.01 Billion |
Market Size (2030) | USD 3 Billion |
CAGR (2025 - 2030) | 8.40 % |
Fastest Growing Market | Asia Pacific |
Largest Market | North America |
Market Concentration | High |
Major Players![]() *Disclaimer: Major Players sorted in no particular order |
Biobank Consumables Market Analysis
The Biobank Consumables Market size is estimated at USD 2.01 billion in 2025, and is expected to reach USD 3 billion by 2030, at a CAGR of 8.40% during the forecast period (2025-2030).
Biobank consumables are essential products used in the collection, preparation, analysis, storage, transport, and monitoring of biological samples. A biobank is a repository of human biological samples, such as bodily fluids or tissues, and associated health information. Biobanks have become critical in advancing research to improve our understanding of health and disease. The rising burden of diseases such as cardiovascular disorders, cancer, diabetes, and rare genetic disorders, along with growing government investments in biobanks, has significantly driven the market's growth at present.
Rising cases of cardiovascular diseases have driven the market’s growth. According to the World Heart Federation, as of April 2023, over half a billion people globally are affected by cardiovascular diseases, which accounted for 20.5 million deaths in 2021—nearly one-third of all global deaths and an increase from the estimated 121 million CVD deaths. Additionally, the British Heart Foundation reported in March 2023 that over 250 million people worldwide are living with coronary heart disease, with approximately 145 million men and 110 million women affected. These factors have fueled the expansion of biobanks, subsequently driving the growth of the biobank consumables market.
Rising cases of diabetes have driven the market’s growth. As of June 2023, the Institute for Health Metrics and Evaluation reported that more than half a billion people globally were living with diabetes, with a prevalence rate of 6.1%. The same source projected that the number of individuals with diabetes could more than double to 1.3 billion over the next 30 years.
Thus, factors such as the rising global incidence of heart disease and the increasing burden of diabetes are key drivers for the growth of biobanks and, consequently, the biobank consumables market.
However, stringent regulations governing biobanking equipment remain a significant challenge to market growth.
Biobank Consumables Market Trends
Sample Storage Tubes Expected to Hold Largest Market Share of the Biobank Consumables Market
Biobanking sample tubes are critical for storing biological samples, such as blood and tissue, along with their associated health data, for research and clinical purposes. The primary objective of biobanking is to preserve the quality of these samples during collection, processing, storage, and distribution. The rising incidence of cancer and increasing government support for biobanks have driven market growth, a trend expected to continue.
Increasing cases of cancer across the world is a primary factor driving the biobank consumables market. As per the Pan American Health Organization, in 2023, there were an estimated 20 million new cancer cases globally, leading to approximately 10 million deaths. The global cancer burden is projected to rise by 60% over the next two decades, with the most significant increases expected in low- and middle-income countries. Researchers utilize biological samples, such as blood and tumor cells, to enhance their understanding of cancer and develop innovative treatments. Biobanks play a key role in storing these samples for future research, highlighting the growing demand for biobanking solutions driven by the increasing prevalence of cancer.
Additionally, government initiatives have further supported the growth of the biobank market. For instance, in August 2024, the BioE3 Policy was introduced to promote sustainable and innovative advancements by investing in the industrialization of biology. This policy focuses on biopolymers, enzymes, innovative proteins, and precision biotherapeutics. Furthermore, in April 2023, GBMI compiled digital data from 24 national cryobanks spanning 15 countries, including Australia, Canada, China, and the USA. As reported by Global Biobank Meta-analysis Initiative (GBMI), approximately 2.2 million genotype samples have been analyzed, identifying nearly 70 million genetic variants, with 40 million examined across multiple biobanks. Thus, such factors have assisted the growth of the biobank consumables market at present and is expected to follow the same trend during the forecast period.
As a result of these factors, the sample storage tubes segment not only held the largest market share in 2023 but is also projected to maintain its leading position throughout the forecast period.

North America Dominated the Biobank Consumables Market in 2023
North America region dominated the biobank consumables market in 2023, supported by increased government initiatives for drug discovery and research, along with the presence of key industry players in the region.
Increasing initiatives taken by government in Canada has resulted the overall market growth. In February 2024, the NeuroVISION-2 Biobank Initiative, which investigates the mechanisms and forecasts of perioperative brain injury, received a multi-year grant from the Canadian Institute of Health Research. In 2022/23, the Terry Fox Research Institute (TFRI) allocated approximately 8% of its funding to support biobanking initiatives in Canada, totaling an investment of USD 1 million. TFRI collaborates with leading researchers from top cancer institutions nationwide to standardize tumor collection methods and establish biobanks accessible to researchers nationwide. These efforts aim to provide high-quality samples, enabling groundbreaking discoveries that can transform cancer research and patient care. This development highlights the region's active efforts to drive demand for biobank consumables market.
Additionally, the growing use of biobanks across various regional applications contributes to market growth. A report published in September 2023 by the International Journal of Molecular Sciences emphasized that establishing and using comprehensive biobanks in neurological research are significantly increasing the demand for advanced biobank equipment in North America. Similarly, in October 2024, the "All of Us Research Program" initiated enrollment for pediatric participants, prioritizing the development of biospecimen collection workflows for children from birth to 6 years. Furthermore, the program invites proposals to design innovative methods and workflows for biospecimen collection targeting children aged 7 to 12 and adolescents transitioning into adulthood. Researchers require high-quality tools for storing, processing, and analysis of biological specimens. This initiative seeks to strengthen U.S. leadership in biotechnology and biomanufacturing by utilizing existing data sources, infrastructure, and training programs. This rise in biobanking activities, combined with the need for reliable and standardized biobanking infrastructure, is accelerating the growth of the biobank consumables market and encouraging investments.

Biobank Consumables Industry Overview
The biobank consumables market is characterized by a consolidated structure, with a few manufacturers dominating a substantial portion of the market share. Prominent companies covered in the report include Thermo Fisher Scientific, Azenta Life Sciences, Greiner Bio-One, Hamilton Company, and VWR International, LLC.
Biobank Consumables Market Leaders
-
Brooks Life Sciences
-
DNA Genotek Inc.
-
Greiner Bio-One
-
Hamilton Company
-
Thermo Fisher Scientific
- *Disclaimer: Major Players sorted in no particular order

Biobank Consumables Market News
- September 2024: The FluidX Tri-Coded Sample Tubes from Azenta Life Sciences are created to maintain sample integrity and ensure a reliable chain of custody for use in compound libraries, biobanks, and cryogenic storage facilities. The external thread design of these tubes prevents overtightening, enhances security, and provides a greater working volume compared to internal thread caps.
- May 2024: UK Biobank's new headquarters at Manchester Science Park will include four advanced Hamilton BiOS automated storage systems, provided by Hamilton Storage Technologies, Inc. The project is supported by a GBP £127.6 million (USD 158.6 million) grant from the UK Research and Innovation (UKRI) Infrastructure Fund. These systems will accommodate over 12 million biological samples, with the potential to store an additional 8 million as the collection grows. By mid-2026, the BiOS LR-14 systems are expected to be fully operational at the Manchester facility, maintaining a steady temperature of minus 80ºC. This temperature will help preserve the samples over time, even as they are accessed and returned to storage.
Biobank Consumables Industry Segmentation
As per the report’s scope, biobanks serve as repositories, gathering biological samples and their related data to fuel research and advance health treatments. These institutions rely on biobanking consumables to cryopreserve samples, ensuring they retain their original properties and are stored at precise temperatures.
The biobanking consumables market is categorized by product type and application. By product type, the market includes sample collection containers, sample preparation & analysis kits, sample storage tubes, and others. Others segment under product type includes nozzles and pipettes, amongst others. By application, the market is segmented into regenerative medicine, drug discovery, and others. Other applications inlude scientific reserach and medical studies. Geographically, the market spans North America, Europe, Asia-Pacific, South America, and the Middle East & Africa. The report details market size and forecasts for 17 countries across these regions, with valuations presented in USD.
By Product Type | Sample Collection Containers | ||
Sample Preparation & Analysis Kits | |||
Sample Storage Tubes | |||
Others | |||
By Application | Regenerative Medicine | ||
Drug Discovery | |||
Other Applications | |||
Geography | North America | United States | |
Canada | |||
Mexico | |||
Europe | Germany | ||
United Kingdom | |||
France | |||
Italy | |||
Spain | |||
Rest of Europe | |||
Asia-Pacific | China | ||
Japan | |||
India | |||
Australia | |||
South Korea | |||
Rest of Asia-Pacific | |||
Middle East and Africa | GCC | ||
South Africa | |||
Rest of Middle East and Africa | |||
South America | Brazil | ||
Argentina | |||
Rest of South America |
Biobank Consumables Market Research FAQs
How big is the Biobank Consumables Market?
The Biobank Consumables Market size is expected to reach USD 2.01 billion in 2025 and grow at a CAGR of 8.40% to reach USD 3 billion by 2030.
What is the current Biobank Consumables Market size?
In 2025, the Biobank Consumables Market size is expected to reach USD 2.01 billion.
Who are the key players in Biobank Consumables Market?
Brooks Life Sciences, DNA Genotek Inc., Greiner Bio-One, Hamilton Company and Thermo Fisher Scientific are the major companies operating in the Biobank Consumables Market.
Which is the fastest growing region in Biobank Consumables Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).
Which region has the biggest share in Biobank Consumables Market?
In 2025, the North America accounts for the largest market share in Biobank Consumables Market.
What years does this Biobank Consumables Market cover, and what was the market size in 2024?
In 2024, the Biobank Consumables Market size was estimated at USD 1.84 billion. The report covers the Biobank Consumables Market historical market size for years: 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Biobank Consumables Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.